SWDAF yields 0.14% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, SWDAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SWDAF + MRK for your $10,000?
Software Aktiengesellschaft provides software development, licensing, maintenance, and IT services in Germany, the United States, and internationally. It operates through three segments: Digital Business Platform, Adabas & Natural, and Professional Services. The company offers Internet of Things (IoT) and analytics solutions comprising Cumulocity IoT for integrating digital equipment and sensors through an IoT device management and application enablement platform, as well as provides streaming analytics for big data analytics in real time and solutions for predictive analytics, artificial intelligence (AI), and machine learning; and TrendMiner, an intuitive Web-based analytics platform for visualization of industrial processes and process data. It also provides webMethods that integrate systems, applications, and processes through application programming interfaces or direct connections and orchestrate them in the form of microservices; ARIS for modeling, documenting, and optimizing business processes; Alfabet, which enables enterprise architecture mapping and optimal decision making for IT investments; Adabas & Natural for transaction processing; and CONNX for data integration, virtualization, and replication. In addition, the company offers professional services, which include implementation, development, and upgrade/migration services. Further, it has strategic alliance with Persistent System to develop industry solutions and accelerators for healthcare and life sciences; banking, financial services, and insurance; and telecommunications. Software Aktiengesellschaft was founded in 1969 and is headquartered in Darmstadt, Germany.
Full SWDAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.